These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20696223)

  • 1. High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate.
    Kojima T; Tsutsumi S; Yamamoto K; Ikeda Y; Moriwaki T
    Int J Pharm; 2010 Oct; 399(1-2):52-9. PubMed ID: 20696223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms by which moisture generates cocrystals.
    Jayasankar A; Good DJ; Rodríguez-Hornedo N
    Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
    Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-infrared spectroscopy for cocrystal screening. A comparative study with Raman spectroscopy.
    Allesø M; Velaga S; Alhalaweh A; Cornett C; Rasmussen MA; van den Berg F; de Diego HL; Rantanen J
    Anal Chem; 2008 Oct; 80(20):7755-64. PubMed ID: 18798651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction crystallization of pharmaceutical molecular complexes.
    Rodríguez-Hornedo N; Nehm SJ; Seefeldt KF; Pagan-Torres Y; Falkiewicz CJ
    Mol Pharm; 2006; 3(3):362-7. PubMed ID: 16749868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding.
    Karki S; Friscić T; Jones W; Motherwell WD
    Mol Pharm; 2007; 4(3):347-54. PubMed ID: 17497885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cocrystallization tendency: the role of intermolecular interactions.
    He G; Jacob C; Guo L; Chow PS; Tan RB
    J Phys Chem B; 2008 Aug; 112(32):9890-5. PubMed ID: 18646803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline-nicotinamide cocrystal formation in physical mixture during storage.
    Ervasti T; Aaltonen J; Ketolainen J
    Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hansen solubility parameter as a tool to predict cocrystal formation.
    Mohammad MA; Alhalaweh A; Velaga SP
    Int J Pharm; 2011 Apr; 407(1-2):63-71. PubMed ID: 21256944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocrystallization via planetary milling: enhancing throughput of solid-state screening methods.
    Bysouth SR; Bis JA; Igo D
    Int J Pharm; 2011 Jun; 411(1-2):169-71. PubMed ID: 21439363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical cocrystals: an overview.
    Qiao N; Li M; Schlindwein W; Malek N; Davies A; Trappitt G
    Int J Pharm; 2011 Oct; 419(1-2):1-11. PubMed ID: 21827842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation mechanism of a new carbamazepine/malonic acid cocrystal polymorph.
    Limwikrant W; Nagai A; Hagiwara Y; Higashi K; Yamamoto K; Moribe K
    Int J Pharm; 2012 Jul; 431(1-2):237-40. PubMed ID: 22537807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
    Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
    Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast dissolving eutectic compositions of curcumin.
    Goud NR; Suresh K; Sanphui P; Nangia A
    Int J Pharm; 2012 Dec; 439(1-2):63-72. PubMed ID: 23041131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocrystal screening of hydroxybenzamides with benzoic acid derivatives: a comparative study of thermal and solution-based methods.
    Manin AN; Voronin AP; Drozd KV; Manin NG; Bauer-Brandl A; Perlovich GL
    Eur J Pharm Sci; 2014 Dec; 65():56-64. PubMed ID: 25218047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, structural analysis, and properties of tenoxicam cocrystals.
    Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
    Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of cocrystal cocktail grinding method for rational screening of pharmaceutical cocrystals.
    Yamamoto K; Tsutsumi S; Ikeda Y
    Int J Pharm; 2012 Nov; 437(1-2):162-71. PubMed ID: 22871562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.